Note: Ingredients listed on restricted chemical lists
EC/CAS
211-190-1
Name of the chemical
Ethanaminium, N-[4-[(4-(diethylamino)phenyl)phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl- and its salts, when used as a substance in hair dye products
Concentration
<0,25
General Information
Version
2.4
Revision date
2022-04-01
Product name
Brilliant Green Bile Broth 2% (BRILA)
Product name
Brilliant Green Bile Broth 2% (BRILA)
Identification on the label/Trade name
Brilliant Green Bile Broth 2% (BRILA) BAC ISO-4831, ISO-4832
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111
Icons in SDS
Company Information
company name
labbox labware s.l
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H317, H319
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
